Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Mangia

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2011
IL28B: A new wager in the skyline of hepatitis C virus infectionAlessandra Mangia
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2010
Individualizing treatment duration in hepatitis C virus genotype 2/3-infected patientsAlessandra Mangia
Cells|January 8, 2023
Biomarkers Use and Development in Hepatology: Insights on the Latest ApplicationsAlessandra Mangia
Hepatology (Baltimore, Md.)|September 3, 2010
Optimal dosage of ribavirinAlessandra Mangia, Angelo Andriulli
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
What's new in HCV genotype 2 treatmentAlessandra Mangia, Leonardo Mottola
Current Gastroenterology Reports|November 25, 2011
Treatment of non-genotype 1 hepatitis C virus patientsAlessandra Mangia, Leonardo Mottola
Minerva Gastroenterologica E Dietologica|January 23, 2016
The current treatment of Hepatitis CAndrea Arleo, Alessandra Mangia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2014
Overall efficacy and safety results of sofosbuvir-based therapies in phase II and III studiesAlessandra Mangia, Valeria Piazzolla
Journal of Hepatology|February 5, 2013
Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosisSavino Bruno, Alessandra Mangia
Hepatology International|March 4, 2014
Insulin resistance, steatosis and hepatitis C virusAlessandra Mangia, Maria Ripoli
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2011
IL28B: A new wager in the skyline of hepatitis C virus infectionAlessandra Mangia
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2010
Individualizing treatment duration in hepatitis C virus genotype 2/3-infected patientsAlessandra Mangia
Cells|January 8, 2023
Biomarkers Use and Development in Hepatology: Insights on the Latest ApplicationsAlessandra Mangia
Hepatology (Baltimore, Md.)|September 3, 2010
Optimal dosage of ribavirinAlessandra Mangia, Angelo Andriulli
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
What's new in HCV genotype 2 treatmentAlessandra Mangia, Leonardo Mottola
Current Gastroenterology Reports|November 25, 2011
Treatment of non-genotype 1 hepatitis C virus patientsAlessandra Mangia, Leonardo Mottola
Minerva Gastroenterologica E Dietologica|January 23, 2016
The current treatment of Hepatitis CAndrea Arleo, Alessandra Mangia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2014
Overall efficacy and safety results of sofosbuvir-based therapies in phase II and III studiesAlessandra Mangia, Valeria Piazzolla
Journal of Hepatology|February 5, 2013
Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosisSavino Bruno, Alessandra Mangia
Hepatology International|March 4, 2014
Insulin resistance, steatosis and hepatitis C virusAlessandra Mangia, Maria Ripoli
Pageof 16